The first double-blind randomized placebo-controlled phase 2 study to assess the efficacy and safety of insulin sensitizer in patients with non-alcoholic steatohepatitis in Asia- an interim report

被引：0
|
作者：
Yeh, Ming-Lun [1 ,2 ]
Huang, Chung-Feng [1 ,2 ,3 ]
Tsai, Pei-Chien [2 ]
Huang, Ching-I [1 ,2 ,3 ]
Dai, Chia-Yen [1 ,2 ,3 ]
Chen, Shinn-Chern [1 ,2 ]
Huang, Jee-Fu [1 ,2 ,3 ,4 ,5 ]
Yu, Ming-Lung [1 ,2 ,4 ,5 ]
Chuang, Wan-Long [1 ,2 ]
机构：
[1] Kaohsiung Med Univ, Fac Internal Med, Coll Med, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan
[3] Kaohsiung Med Univ Hosp, Grad Inst Clin Med, Kaohsiung, Taiwan
[4] Kaohsiung Med Univ Hosp, Ctr Liquid Biopsy, Kaohsiung, Taiwan
[5] Kaohsiung Med Univ Hosp, Canc Res Ctr, Kaohsiung, Taiwan
来源：
JOURNAL OF HEPATOLOGY | 2020年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI101
引用
收藏
页码：S449 / S449
页数：1
相关论文
共 50 条
  • [31] Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial
    Nogueira, Monize Aydar
    Oliveira, Claudia Pinto
    Ferreira Alves, Venancio Avancini
    Stefano, Jose Tadeu
    dos Reis Rodrigues, Livia Samara
    Torrinhas, Raquel Susana
    Cogliati, Bruno
    Barbeiro, Hermes
    Carrilho, Flair Jose
    Waitzberg, Dan Linetzky
    CLINICAL NUTRITION, 2016, 35 (03) : 578 - 586
  • [32] Efficacy and Safety of Omilancor in a Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Ulcerative Colitis
    Leber, Andrew
    Hontecillas, Raquel
    Juni, Nuria Tubau
    Bassaganya-Riera, Josep
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S821 - S821
  • [33] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [34] A randomized, double-blind, placebo-controlled phase 2 study to assess safety, tolerability, and efficacy of RT001 in patients with amyotrophic lateral sclerosis
    Weemering, Daphne N.
    Midei, Mark
    Milner, Peter
    Gopalakrishnan, Vidhya
    Kumar, Anil
    Dannenberg, Andrew J.
    Bunte, Tommy M.
    Foucher, Juliette
    Ingre, Caroline
    Kenina, Viktorija
    Rallmann, Karin
    van den Berg, Leonard H.
    van Eijk, Ruben P. A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3722 - 3731
  • [35] EFFICACY AND SAFETY OF QUETIAPINE FOR DELIRIUM IN ICU PATIENTS:A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Devlin, John W.
    Roberts, Russel
    Fong, Jeffrey J.
    Skrobik, Yoanna
    Harvey, Johanne
    Riker, Richard
    Robbins, Tracey
    Hill, Nicholas
    Garpestad, Erik
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A17 - A17
  • [36] A randomized, double-blind, placebo-controlled, Phase 2 study: the efficacy of fasudil in patients with stable angina
    Vicari, RM
    Smith, WB
    Chaitman, B
    Chrysant, SG
    Tonkon, MJ
    Bitter, N
    Weiss, RJ
    Thadani, U
    EUROPEAN HEART JOURNAL, 2004, 25 : 138 - 138
  • [37] Efficacy and safety of etrasimod in alopecia areata: A multicentre, randomized, double-blind, placebo-controlled, Phase 2 study
    King, B.
    Mesinkovska, N.
    Senna, M.
    Luo, X.
    Minkiewicz, J.
    Selfridge, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [38] Efficacy and Safety of AMG 853 in Asthma: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Busse, W. W.
    Wenzel, S. E.
    Meltzer, E. O.
    Kerwin, E. M.
    Liu, M. C.
    Zhang, N.
    Chon, Y.
    Lin, J.
    Lin, S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2012, 129 (02) : AB202 - AB202
  • [39] A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis
    Peters, Eric
    Chou, Richard C.
    Rozzo, Stephen J.
    Yao, Siu-Long
    Fructuoso, Ferran Jose Garcia
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2023, 29 (05) : 223 - 229
  • [40] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF GEVOKIZUMAB IN THE TREATMENT OF GIANT CELL ARTERITIS
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2014, 53 : 7 - 7
12345